Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SEC Rule 10b5-1
I gotta disagree with you as if, FOR EXAMPLE ONLY, the J3 settlements were for $3M total, you can be certain when that becomes public knowledge in the next 10Q, the pps will TANK. Swartz being able to sell now, prior to that release of info benefits him greatly.
Share
New Message
Please login to post a reply